With the U.S. economy in recovery mode and Europe’s debt crisis easing, at least for now, debt remains a big issue for American consumers and corporations, and the government.
Given the continued shift to oil, Cramer thinks select oil and gas names can be bought on dips. Check out his preferred plays.
Expert Analysis, Investment Tools, Stock Screeners, and Financial Strategy Information.
Corporate Company Earnings, Find Earnings Per Share and Earnings History Online
Trader Talk with Bob Pisani provides a dynamic look at the reasons for the day’s actions on Wall Street.
Your daily guide to events and trends that drive the financial markets.
You'll find stock picks, news about publicly-traded companies, commodities, hot sectors, ETFs and the latest options action.
CNBC's market specialists dig deep into Wall Street’s daily metrics, crunching the numbers to help you become smarter about the market so that you can make better investment decisions.
How can you get out of debt and back on the road to recovery?Click to see renowned financial author and Til Debt Do Us Part host Gail Vaz-Oxlade's 10 Tips To Get Out of Debt.
How can you protect yourself from being scammed? Click to see which investment vehicles are ranked high for fraud and get tips to make sure it doesn't happen to you.
You may be surprised how quickly these 10 simple changes can add up to real money in your pocket.
Here are the 15 publicly traded stocks, by value, that are the biggest holdings of Berkshire Hathaway.
Historically, dividend payments have accounted for more than 40 percent of the S&P 500’s total returns. Here are the top companies with 15 years or more of consecutive dividend increases.
To play the potential housing turn around, Cramer doesn’t recommend buying homebuilder stocks. Read on for his preferred plays.
Why are commercial banks and the federal government asking so many Americans to take out new mortgages with much more favorable terms? Fees, votes, and politics.
Expedia shares dropped nearly 3 percent Friday after the company missed revenue estimates for the second quarter.
Seres Therapeutics shares plummeted more than 76 percent after its drug for preventing a bacterial infection of the large intestine failed.
Vanguard shuts new investors out of dividend growth fund, as market shows signs pace of dividends won't hold up.